Theriva Biologics (TOVX) Preferred Dividend Payments (2017 - 2021)
Theriva Biologics (TOVX) posted quarterly Preferred Dividend Payments of -$1.5 million for Q4 2021, down 2366.15% year-over-year from $65000.0 in Q4 2020, and down 6237.5% quarter-over-quarter from $24000.0 in Q1 2021.
Theriva Biologics (TOVX) Preferred Dividend Payments (2017 - 2021) Analysis & Trends
Theriva Biologics (TOVX) has reported Preferred Dividend Payments for 5 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Dividend Payments fell 2366.15% year-over-year to -$1.5 million; the TTM figure through Jun 2022 stood at -$1.5 million (down 1062.75% YoY), while the FY2021 annual figure was $24000.0, down 90.55% from the prior year.
- Preferred Dividend Payments slipped to -$1.5 million in Q4 2021 per TOVX's latest filing, from $24000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $6.9 million in Q3 2017 and bottomed at -$1.5 million in Q4 2021.
- Historically, Preferred Dividend Payments has averaged $421066.7 across 5 years, with a median of $62000.0 in 2020.
- Annual changes were most pronounced in 2018 — Preferred Dividend Payments surged 24400.0% — and 2021, when it plunged 2366.15%.
- Theriva Biologics' Preferred Dividend Payments stood at -$1000.0 in 2017, then soared by 24400.0% to $243000.0 in 2018, then tumbled by 74.07% to $63000.0 in 2019, then rose by 3.17% to $65000.0 in 2020, then slumped by 2366.15% to -$1.5 million in 2021.
- Business Quant data shows TOVX's Preferred Dividend Payments at -$1.5 million in Q4 2021, $24000.0 in Q1 2021, and $65000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.47 Mn |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 65,000.00 |
| Sep 30, 2020 | 64,000.00 |
| Jun 30, 2020 | 63,000.00 |
| Mar 31, 2020 | 62,000.00 |
| Dec 31, 2019 | 63,000.00 |
| Sep 30, 2019 | 63,000.00 |
| Jun 30, 2019 | 61,000.00 |
| Mar 31, 2019 | 61,000.00 |
| Dec 31, 2018 | 243,000.00 |
| Jun 30, 2018 | 61,000.00 |
| Mar 31, 2018 | 59,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Sep 30, 2017 | 6.90 Mn |